Related Experiment Video
Updated: Nov 11, 2025

11:27
A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
9.4K
The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders
Soudeh Ghafouri-Fard1, Afete Abak2, Faranak Fattahi3
1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Summary
Nuclear factor-kappa B (NF-κB) interacts with non-coding RNAs like miRNAs and lncRNAs to regulate gene expression. This complex network is crucial in neoplastic and non-neoplastic disorders.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- Nuclear factor-kappa B (NF-κB) is a key transcription factor regulating immune responses and gene expression.
- NF-κB interacts with non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), forming complex regulatory networks.
- These interactions are implicated in the pathophysiology of various human diseases, encompassing both neoplastic and non-neoplastic conditions.
Purpose of the Study:
- To review the intricate functions of NF-κB-related miRNAs and lncRNAs.
- To explore their roles in the development and progression of neoplastic and non-neoplastic human disorders.
Main Methods:
- Literature review focusing on studies investigating NF-κB interactions with miRNAs and lncRNAs.
- Analysis of functional relationships and regulatory mechanisms.
- Examination of roles in cancer and inflammatory conditions.
Main Results:
- NF-κB forms complex regulatory networks with miRNAs and lncRNAs, influencing gene expression.
- Specific lncRNAs like MALAT1 and NKILA, and miRNAs such as miR-146a/b, have demonstrated functional interactions with NF-κB.
- The regulatory role of miRNAs on NF-κB is more extensively characterized than that of lncRNAs.
Conclusions:
- NF-κB-associated non-coding RNAs are critical players in human diseases.
- Understanding these interactions offers potential therapeutic targets for neoplastic and non-neoplastic conditions.
- Further research into lncRNA-NF-κB interactions is warranted.
Related Concept Videos
NF-κB-dependent Signaling Pathway
8.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.5K
Co-activators and Co-repressors
8.0K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.0K
lncRNA - Long Non-coding RNAs
9.3K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
Transducer Mechanism: Nuclear Receptors
2.0K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.0K
The Nucleolus
9.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.7K
Regulation of Nuclear Protein Sorting
2.9K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.9K

